[1] MILLER A L. The methionine-homocysteine cycle and its effects on cognitive diseases[J]. Altern Med Rev,2003,8(1):7-19.
[2] TROEN A M,LUTGENS E,SMITH D E,et al. The atherogenic effect of excess methionine intake[J]. PNAS,2003,100(25):15089-15094.
[3] LENTZ S R. Mechanisms of homocysteine-induced atherothrombosis[J]. Thromb Haemost,2005,3(8):1646-1654.
[4] SMITH A D,REFSUM H,BOTTIGLIERI T,et al. Homocysteine and dementia:An international consensus statement[J]. J Alzheimers Dis, 2018,62(2):561-570.
[5] HU Q, TENG W, LI J, et al., Homocysteine and Alzheimer's disease:Evidence for a causal link from Mendelian randomization[J]. J Alzheimers Dis,2016,52(2):747-756.
[6] ZHANG C E, WEI W, LIU Y H, et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain[J]. Am J Pathol,2009,174(4):1481-1491.
[7] ZHUO J M, WANG H, PRATICÒ D. Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither[J]. Trends Pharmacol Sci,2011,32(9):562-571.
[8] SHARMA M,TIWARI M,TIWARI R K. Hyperhomocysteinemia:Impact on neurodegenerative diseases[J]. Basic Clin Pharmacol Toxicol,2015,117(5):287-296.
[9] SCARPA S, FUSO A, D'ANSELMI F, et al. Presenilin 1 gene silencing by S-adenosylmethionine:a treatment for Alzheimer disease[J]. FEBS Lett,2003,541(1):145-148.
[10] FUSO A, SEMINARA L, CAVALLARO R A, et al. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production[J]. Mol Cell Neurosci, 2005, 28(1):195-204.
[11] LEE M S, KAO S C, LEMERE C A, et al. APP processing is regulated by cytoplasmic phosphorylation[J]. J Cell Biol Histol,2003, 163(1):83-95.
[12] LI J,BARRERO C,GUPTA S,et al. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation[J]. Aging Cell, 2017,16(2):273-280.
[13] DI A M,LI J G,PRATICÒ D. Dissecting the role of 5-lipoxygenase in the homocysteine-induced Alzheimer's disease pathology[J]. Alzheimers Dis,2017,62(3):1337-1344.
[14] CHONG F P,NG K Y,KOH R Y,et al. Tau proteins and Tauopathies in Alzheimer's disease[J]. Cell Mol Neurobiol,2018,38(5):965-980.
[15] SONTAG J M, WASEK B, TALESKI G, et al. Altered protein phosphatase 2A methylation and Tau phosphorylation in the young and aged brain of methylenetetrahydrofolate reductase (MTHFR) deficient mice[J]. Front Aging Neurosci,2014,6(9):1-10.
[16] SHIRAFUJI N, HAMANO T, YEN S H, et al. Homocysteine increases Tau phosphorylation,truncation and oligomerization[J]. Int J Mol Sci,2018,19(3):1-24.
[17] MECO A D,LI J G,BARRERO C,et al. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy[J]. Mol Psychiatry,2018. doi:10.1038/s41380-018-0062-0.
[18] ZETTERBERG H. Review:Tau in biofluids-relation to pathology, imaging and clinical features[J]. Neuropathol Appl Neurobiol,2017, 43(3):194-199.
[19] DI A M,LI J G,PRATICÒ D. Dissecting the role of 5-lipoxygenase in the homocysteine-induced Alzheimer's disease pathology[J]. Alzheimers Dis,2017,62(3):1337-1344.
[20] VANZIN C S, MANFREDINI V, MARINHO A E, et al. Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients[J]. Gene,2014,539(2):270-274.
[21] WANG D,CHEN Y M,RUAN M H,et al. Homocysteine inhibits neural stem cells survival by inducing DNA interstrand cross-links via oxidative stress[J]. Neurosci Lett,2016,635:24-32.
[22] LIN N,QIN S,LUO S,et al. Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation invitro[J]. FEBS J,2014,281(8):2088-2096.
[23] COLLINS A R. Measuring oxidative damage to DNA and its repair with the comet assay[J]. Biochim Biophys Acta,2014,1840(2):794-800.
[24] CURRÒM,GUGLIANDOLO A,GANGEMI C,et al. Toxic effects o mildly elevated homocysteine concentrations in neuronal-like cells[J] Neurochem Res,2014,39(8):1485-1495.
[25] GUO CHENG,DING PEILI,XIE CONG,et al. Potential application of the oxidative nucleic acid damage biomarkers in detection o diseases[J]. Oncotarget,2017,8(43):75767-75777.
[26] CHEN S, DONG Z, ZHAO Y, et al. Homocysteine induces mitochondrial dysfunction involving the crosstalk between oxidative stress and mitochondrial pSTAT3 in rat ischemic brain[J]. Sci Rep, 2017,7(1):1-12.
[27] PARZYCH K R, KLIONSKY D J. An overview of autophagy:morphology,mechanism,and regulation[J]. Antioxid Redox Signal, 2014,20(3):460-473.
[28] ZARE-SHAHABADI A, MASLIAH E, JOHNSON G V, et al Autophagy in Alzheimer's disease[J]. Rev Neurosci, 2015, 26(4):385-395.
[29] KHAYATI K,ANTIKAINEN H,BONDER E M,et al. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice[J]. FASEB J, 2017,31(2):598-609.
[30] MENON S,DIBBLE C C,TALBOTT G,et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome[J]. Cell,2014,156(4):771-785.
[31] YAO J,ZHENG K,LI C,et al. Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway[J]. Med Oncol,2015, 32(6):1-8.
[32] ZHANG J W,YAN R,TANG Y S,et al. Hyperhomocysteinemia induced autophagy and apoptosis with downregulation of hairy enhancer of split 1/5 in cortical neurons in mice[J]. Int J Immunopathol Pharmacol,2017,30(4):371-382.
[33] NEELY K M,GREEN K N,LAFERLA F M. Presenilin is necessary for efficient proteolysis through the autophagy-lysosome system in a γ-secretase independent manner[J]. J Neurosci, 2011, 31(6):2781-2791.
[34] LEE J H,YU W H,KUMAR A,et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations[J]. Cell,2010,141(7):1146-1158.
[35] ZHAO Y, HUANG G, CHEN S, et al. Homocysteine aggravates cortical neural cell injury through neuronal autophagy overactivation following rat cerebral ischemia-reperfusion[J]. Int J Mol Sci,2016, 17(8):1-13.
[36] CHAUDHURY S,PATEL T,BARBER I S,et al. Polygenic risk score in post-mortem diagnosed sporadic early onset Alzheimer's disease[J]. Neurobiol Aging,2017,62:1-8.
[37] WANG J C,ALINAGHI S,TAFAKHORI A,et al. Genetic screening in two Iranian families with early-onset Alzheimer's disease identified a novel PSEN1 mutation[J]. Neurobiol Aging,2018,62:15-17.
[38] KUŹMA E,HANNON E,ZHOU A,et al. Which risk factors causally influence dementia? A systematic review of mendelian randomization studies[J]. J Alzheimers Dis,2018,64(1):181-193. |
